VIJAYA DIAGNOSTIC CENTRE
|
VIJAYA DIAGNOSTIC CENTRE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 16.81 | 14.01 | 11.61 | 8.29 | 10.76 |
| CEPS(Rs) | 25.73 | 20.89 | 17.26 | 14.39 | 16.02 |
| DPS(Rs) | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 92.73 | 76.29 | 64.09 | 53.18 | 45.73 |
| Tax Rate(%) | 25.66 | 25.56 | 24.61 | 24.93 | 24.91 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 41.38 | 40.10 | 39.74 | 39.64 | 44.05 |
| EBIT Margin(%) | 32.66 | 32.27 | 33.35 | 29.28 | 35.43 |
| Pre Tax Margin(%) | 28.58 | 28.35 | 28.97 | 24.72 | 31.88 |
| PAT Margin (%) | 21.24 | 21.10 | 21.84 | 18.55 | 23.93 |
| Cash Profit Margin (%) | 32.52 | 31.46 | 32.24 | 31.99 | 35.33 |
| Performance Ratios | |||||
| ROA(%) | 12.44 | 12.76 | 13.11 | 11.00 | 17.85 |
| ROE(%) | 19.91 | 19.99 | 19.96 | 16.89 | 26.85 |
| ROCE(%) | 30.28 | 30.20 | 30.40 | 26.53 | 39.37 |
| Asset Turnover(x) | 0.59 | 0.60 | 0.60 | 0.59 | 0.75 |
| Sales/Fixed Asset(x) | 0.58 | 0.59 | 0.59 | 0.66 | 0.90 |
| Working Capital/Sales(x) | 4.11 | 4.71 | 3.96 | 2.19 | 2.27 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.72 | 1.71 | 1.71 | 1.51 | 1.11 |
| Receivable days | 7.98 | 8.30 | 8.57 | 7.65 | 6.50 |
| Inventory Days | 2.20 | 2.71 | 2.41 | 2.51 | 2.73 |
| Payable days | 136.27 | 142.28 | 169.19 | 152.97 | 111.80 |
| Valuation Parameters | |||||
| PER(x) | 51.24 | 71.86 | 54.69 | 47.18 | 40.70 |
| PCE(x) | 33.47 | 48.20 | 36.79 | 27.18 | 27.32 |
| Price/Book(x) | 9.29 | 13.20 | 9.91 | 7.36 | 9.57 |
| Yield(%) | 0.23 | 0.20 | 0.16 | 0.26 | 0.23 |
| EV/Net Sales(x) | 10.82 | 15.09 | 11.73 | 8.44 | 9.24 |
| EV/Core EBITDA(x) | 24.63 | 35.28 | 26.58 | 19.76 | 19.73 |
| EV/EBIT(x) | 33.14 | 46.77 | 35.18 | 28.83 | 26.07 |
| EV/CE(x) | 9.21 | 12.87 | 9.78 | 7.12 | 9.11 |
| M Cap / Sales | 10.89 | 15.16 | 11.86 | 8.70 | 9.65 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.49 | 24.39 | 19.29 | -0.68 | 22.73 |
| Core EBITDA Growth(%) | 22.71 | 20.61 | 23.21 | -9.40 | 21.76 |
| EBIT Growth(%) | 20.92 | 20.39 | 35.86 | -17.93 | 28.63 |
| PAT Growth(%) | 20.30 | 20.19 | 40.41 | -23.01 | 30.00 |
| EPS Growth(%) | 19.99 | 20.67 | 40.03 | -22.92 | -42.30 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.60 | 1.89 | 2.90 | 4.17 | 4.08 |
| Quick Ratio(x) | 2.56 | 1.86 | 2.83 | 4.14 | 4.02 |
| Interest Cover(x) | 8.00 | 8.22 | 7.61 | 6.42 | 9.96 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of VIJAYA DIAGNOSTIC CENTRE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIJAYA DIAGNOSTIC CENTRE | ₹15,609.7 Cr | -2.7% | 3.2% | 44.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,823.0 Cr | -0.6% | 1.1% | 14% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,693.7 Cr | -4.7% | 0.2% | -9.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹66,181.7 Cr | 0.4% | -0.4% | 17.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,046.6 Cr | -6.9% | -9% | -8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,040.7 Cr | -1.8% | -1.2% | 5.6% | Stock Analytics | |
VIJAYA DIAGNOSTIC CENTRE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIJAYA DIAGNOSTIC CENTRE | -2.7% |
3.2% |
44.5% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses